Adebrelimab (SHR-1316) in Combination With Chemotherapy as Perioperative Treatment in Patients With Resectable Stage II to III NSCLCs: An Open-Label, Multicenter, Phase 1b TrialWanpu Yan, Yi‐Long Wu, Ke‐Neng Chen et al.|Journal of Thoracic Oncology|2022Cited by 34
Genome-scale CRISPR activation screening identifies a role of ELAVL2-CDKN1A axis in paclitaxel resistance in esophageal squamous cell carcinoma.Wensi Zhao, Ke‐Neng Chen, Wanpu Yan et al.|PubMed|2019Cited by 31
IGFBP1hiWNT3Alo Subtype in Esophageal Cancer Predicts Response and Prolonged Survival with PD-(L)1 InhibitorMeichen Liu, Ke‐Neng Chen, Dongbo Chen et al.|Biology|2022Cited by 3
Correction: The utility of 18F-FDG PET/CT for predicting the pathological response and prognosis to neoadjuvant immunochemotherapy in resectable non-small-cell lung cancerRui Guo, Nan Li, Wanpu Yan et al.|Cancer Imaging|2024Cited by 1